NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma.
Molecular Therapy Oncolytics
Kennedy, Barry E BE; Giacomantonio, Michael M; Murphy, J Patrick JP; Cutler, Samuel S; Sadek, Maryanne M; Konda, Prathyusha P; Paulo, Joao A JA; Pathak, Gopal P GP; Renkens, Saskia H J SHJ; Grieve, Stacy S; Pol, Jonathan J; Gygi, Steven P SP; Richardson, Christopher C; Gaston, Daniel D; Reiman, Anthony A; Kroemer, Guido G; Elnenaei, Manal O MO; Gujar, Shashi A SA
A Cross-Sectional Study for Evaluation of KRAS and BRAF Mutations by Reverse Dot Blot, PCR-RFLP, and Allele-Specific PCR Methods Among Patients with Colorectal Cancer.
KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival.
Leukemia
Vendramini, Elena E; Bomben, Riccardo R; Pozzo, Federico F; Benedetti, Dania D; Bittolo, Tamara T; Rossi, Francesca Maria FM; Dal Bo, Michele M; Rabe, Kari G KG; Pozzato, Gabriele G; Zaja, Francesco F; Chiarenza, Annalisa A; Di Raimondo, Francesco F; Braggio, Esteban E; Parikh, Sameer A SA; Kay, Neil E NE; Shanafelt, Tait D TD; Del Poeta, Giovanni G; Gattei, Valter V; Zucchetto, Antonella A
Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.
Oncotarget
Módos, Orsolya O; Reis, Henning H; Niedworok, Christian C; Rübben, Herbert H; Szendröi, Attila A; Szász, Marcell A MA; Tímár, József J; Baghy, Kornélia K; Kovalszky, Ilona I; Golabek, Tomasz T; Chlosta, Piotr P; Okon, Krzysztof K; Peyronnet, Benoit B; Mathieu, Romain R; Shariat, Shahrokh F SF; Hollósi, Péter P; Nyirády, Péter P; Szarvas, Tibor T
ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma.
Oncotarget
Hutchinson, Katherine E KE; Johnson, Douglas B DB; Johnson, Adam S AS; Sanchez, Violeta V; Kuba, Maria M; Lu, Pengcheng P; Chen, Xi X; Kelley, Mark C MC; Wang, Qingguo Q; Zhao, Zhongming Z; Kris, Mark M; Berger, Michael F MF; Sosman, Jeffrey A JA; Pao, William W
Detection of the BRAF V600E mutation in colon carcinoma: critical evaluation of the imunohistochemical approach.
The American Journal Of Surgical Pathology
Lasota, Jerzy J; Kowalik, Artur A; Wasag, Bartosz B; Wang, Zeng-Feng ZF; Felisiak-Golabek, Anna A; Coates, Tiffany T; Kopczynski, Janusz J; Gozdz, Stanislaw S; Miettinen, Markku M
Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibition.
International Journal Of Cancer
Mayes, Patrick A PA; Degenhardt, Yan Y YY; Wood, Andrew A; Toporovskya, Yana Y; Diskin, Sharon J SJ; Haglund, Elizabeth E; Moy, Christopher C; Wooster, Richard R; Maris, John M JM